TP53BP1
































































TP53BP1
Protein TP53BP1 PDB 1gzh.png







Available structures
PDB Ortholog search: PDBe RCSB



Identifiers
Aliases
TP53BP1, 53BP1, p202, p53BP1, TP53, TDRD30, tumor protein p53 binding protein 1
External IDs MGI: 1351320 HomoloGene: 4137 GeneCards: TP53BP1


















Gene location (Human)
Chromosome 15 (human)
Chr. Chromosome 15 (human)[1]

Chromosome 15 (human)
Genomic location for TP53BP1

Genomic location for TP53BP1

Band 15q15.3 Start 43,403,061 bp[1]
End 43,510,728 bp[1]























RNA expression pattern
PBB GE TP53BP1 203050 at fs.png
More reference expression data















Orthologs
Species Human Mouse
Entrez


7158


27223
Ensembl


ENSG00000067369


ENSMUSG00000043909
UniProt


Q12888


P70399
RefSeq (mRNA)


NM_001141979
NM_001141980
NM_005657
NM_001355001


NM_001290830
NM_013735
RefSeq (protein)


NP_001135451
NP_001135452
NP_005648
NP_001341930


NP_001277759
NP_038763
Location (UCSC) Chr 15: 43.4 – 43.51 Mb Chr 2: 121.19 – 121.27 Mb

PubMed search		 [3] [4]
Wikidata



View/Edit Human View/Edit Mouse

Tumor suppressor p53-binding protein 1 also known as p53-binding protein 1 or 53BP1 is a protein that in humans is encoded by the TP53BP1 gene.[5][6][7]




Contents






  • 1 Clinical significance


  • 2 DNA repair


  • 3 Interactions


  • 4 References


  • 5 Further reading





Clinical significance


53BP1 is underexpressed in most cases of triple-negative breast cancer.[8]



DNA repair


DNA double-strand breaks (DSBs) are cytotoxic damages that can be repaired either by the homologous recombinational repair (HR) pathway or by the non-homologous end-joining (NHEJ) pathway. NHEJ, although faster than HR, is less accurate. The early divergent step between the two pathways is end resection, and this step is regulated by numerous factors. In particular, BRCA1 and 53BP1 play a role in determining the balance between the two pathways.[9][10] 53BP1 restricts resection and promotes NHEJ.


Trimethylated histone H4 at lysine 20 (H4K20me3) functions in DNA repair as a binding site for 53BP1.[11] The cellular level of H4K20me3 is increased by DNA damaging radiation. Another trimethylated histone, H3K9me3, also interacts with 53BP1. In addition, H4K20me2 and H3K79me2 facilitate the recruitment of 53BP1 to chromatin in the vicinity of a DNA double-strand break. Thus H4K20me3, H3K9me3, H4K20me2 and H3K79me2 are epigenetic markers that are important for the function of the 53BP1 in NHEJ repair of DNA double-strand breaks.



Interactions


53BP1 has been shown to physically interact with:





  • Histone H4 dimethylated or monomethylated at Lysine 20[12]


  • p53[13][14][15][16]


  • DYNLL1[17]




References





  1. ^ abc GRCh38: Ensembl release 89: ENSG00000067369 - Ensembl, May 2017


  2. ^ abc GRCm38: Ensembl release 89: ENSMUSG00000043909 - Ensembl, May 2017


  3. ^ "Human PubMed Reference:"..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  4. ^ "Mouse PubMed Reference:".


  5. ^ Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S (Jun 1994). "Two cellular proteins that bind to wild-type but not mutant p53". Proceedings of the National Academy of Sciences of the United States of America. 91 (13): 6098–102. doi:10.1073/pnas.91.13.6098. PMC 44145. PMID 8016121.


  6. ^ Iwabuchi K, Li B, Massa HF, Trask BJ, Date T, Fields S (Oct 1998). "Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2". The Journal of Biological Chemistry. 273 (40): 26061–8. doi:10.1074/jbc.273.40.26061. PMID 9748285.


  7. ^ "Entrez Gene: TP53BP1 tumor protein p53 binding protein 1".


  8. ^ Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q, Haffty BG, Tommiska J, Blomqvist C, Drapkin R, Adams DJ, Nevanlinna H, Bartek J, Tarsounas M, Ganesan S, Jonkers J (Jun 2010). "53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers". Nature Structural & Molecular Biology. 17 (6): 688–95. doi:10.1038/nsmb.1831. PMC 2912507. PMID 20453858.


  9. ^ Panier S, Boulton SJ (2014). "Double-strand break repair: 53BP1 comes into focus". Nat. Rev. Mol. Cell Biol. 15 (1): 7–18. doi:10.1038/nrm3719. PMID 24326623.


  10. ^ Li J, Xu X (2016). "DNA double-strand break repair: a tale of pathway choices". Acta Biochim. Biophys. Sin. (Shanghai). 48 (7): 641–6. doi:10.1093/abbs/gmw045. PMID 27217474.


  11. ^ Svobodová Kovaříková A, Legartová S, Krejčí J, Bártová E (October 2018). "H3K9me3 and H4K20me3 represent the epigenetic landscape for 53BP1 binding to DNA lesions". Aging (Albany NY). 10 (10): 2585–2605. doi:10.18632/aging.101572. PMID 30312172.


  12. ^ Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, Mer G (Dec 2006). "Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair". Cell. 127 (7): 1361–73. doi:10.1016/j.cell.2006.10.043. PMC 1804291. PMID 17190600.


  13. ^ Derbyshire DJ, Basu BP, Serpell LC, Joo WS, Date T, Iwabuchi K, Doherty AJ (Jul 2002). "Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor". The EMBO Journal. 21 (14): 3863–72. doi:10.1093/emboj/cdf383. PMC 126127. PMID 12110597.


  14. ^ Ekblad CM, Friedler A, Veprintsev D, Weinberg RL, Itzhaki LS (Mar 2004). "Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis". Protein Science. 13 (3): 617–25. doi:10.1110/ps.03461404. PMC 2286730. PMID 14978302.


  15. ^ Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP (Mar 2002). "Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure". Genes & Development. 16 (5): 583–93. doi:10.1101/gad.959202. PMC 155350. PMID 11877378.


  16. ^ Derbyshire DJ, Basu BP, Date T, Iwabuchi K, Doherty AJ (Oct 2002). "Purification, crystallization and preliminary X-ray analysis of the BRCT domains of human 53BP1 bound to the p53 tumour suppressor". Acta Crystallographica Section D. 58 (Pt 10 Pt 2): 1826–9. doi:10.1107/S0907444902010910. PMID 12351827.


  17. ^ Lo KW, Kan HM, Chan LN, Xu WG, Wang KP, Wu Z, Sheng M, Zhang M (Mar 2005). "The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation". The Journal of Biological Chemistry. 280 (9): 8172–9. doi:10.1074/jbc.M411408200. PMID 15611139.




Further reading


.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}



  • Choubey D, Lengyel P (Mar 1995). "Binding of an interferon-inducible protein (p202) to the retinoblastoma protein". The Journal of Biological Chemistry. 270 (11): 6134–40. doi:10.1074/jbc.270.11.6134. PMID 7890747.


  • Choubey D, Li SJ, Datta B, Gutterman JU, Lengyel P (Oct 1996). "Inhibition of E2F-mediated transcription by p202". The EMBO Journal. 15 (20): 5668–78. PMC 452311. PMID 8896460.


  • Datta B, Li B, Choubey D, Nallur G, Lengyel P (Nov 1996). "p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition". The Journal of Biological Chemistry. 271 (44): 27544–55. doi:10.1074/jbc.271.44.27544. PMID 8910340.


  • Wen Y, Yan DH, Spohn B, Deng J, Lin SY, Hung MC (Jan 2000). "Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells". Cancer Research. 60 (1): 42–6. PMID 10646849.


  • Xia Z, Morales JC, Dunphy WG, Carpenter PB (Jan 2001). "Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1". The Journal of Biological Chemistry. 276 (4): 2708–18. doi:10.1074/jbc.M007665200. PMID 11042216.


  • Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP (Mar 2002). "Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure". Genes & Development. 16 (5): 583–93. doi:10.1101/gad.959202. PMC 155350. PMID 11877378.


  • Derbyshire DJ, Basu BP, Serpell LC, Joo WS, Date T, Iwabuchi K, Doherty AJ (Jul 2002). "Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor". The EMBO Journal. 21 (14): 3863–72. doi:10.1093/emboj/cdf383. PMC 126127. PMID 12110597.


  • Lai H, Lin L, Nadji M, Lai S, Trapido E, Meng L (2002). "Mutations in the p53 tumor suppressor gene and early onset breast cancer". Cancer Biology & Therapy. 1 (1): 31–6. doi:10.4161/cbt.1.1.37. PMID 12170762.


  • Derbyshire DJ, Basu BP, Date T, Iwabuchi K, Doherty AJ (Oct 2002). "Purification, crystallization and preliminary X-ray analysis of the BRCT domains of human 53BP1 bound to the p53 tumour suppressor". Acta Crystallographica Section D. 58 (Pt 10 Pt 2): 1826–9. doi:10.1107/S0907444902010910. PMID 12351827.


  • Wang B, Matsuoka S, Carpenter PB, Elledge SJ (Nov 2002). "53BP1, a mediator of the DNA damage checkpoint". Science. 298 (5597): 1435–8. doi:10.1126/science.1076182. PMID 12364621.


  • Richie CT, Peterson C, Lu T, Hittelman WN, Carpenter PB, Legerski RJ (Dec 2002). "hSnm1 colocalizes and physically associates with 53BP1 before and after DNA damage". Molecular and Cellular Biology. 22 (24): 8635–47. doi:10.1128/MCB.22.24.8635-8647.2002. PMC 139863. PMID 12446782.


  • DiTullio RA, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J, Halazonetis TD (Dec 2002). "53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer". Nature Cell Biology. 4 (12): 998–1002. doi:10.1038/ncb892. PMID 12447382.


  • Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, Carpenter PB, Bonner WM, Chen J, Nussenzweig A (Dec 2002). "DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1". Nature Cell Biology. 4 (12): 993–7. doi:10.1038/ncb884. PMID 12447390.


  • Peng A, Chen PL (Mar 2003). "NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage". The Journal of Biological Chemistry. 278 (11): 8873–6. doi:10.1074/jbc.C300001200. PMID 12551934.


  • Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ (Feb 2003). "MDC1 is a mediator of the mammalian DNA damage checkpoint". Nature. 421 (6926): 961–6. doi:10.1038/nature01446. PMID 12607005.


  • Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K (Mar 2003). "P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells". Biochemical and Biophysical Research Communications. 303 (1): 219–22. doi:10.1016/S0006-291X(03)00320-6. PMID 12646190.


  • Kao GD, McKenna WG, Guenther MG, Muschel RJ, Lazar MA, Yen TJ (Mar 2003). "Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response". The Journal of Cell Biology. 160 (7): 1017–27. doi:10.1083/jcb.200209065. PMC 2172769. PMID 12668657.


  • Caldwell RB, Braselmann H, Schoetz U, Heuer S, Scherthan H, Zitzelsberger H (July 4, 2016). "Positive Cofactor 4 (PC4) is critical for DNA repair pathway re-routing in DT40 cells". Sci. Rep. 6: 28890. doi:10.1038/srep28890. PMC 4931448. PMID 27374870.











-

Popular posts from this blog

澳門輕軌系統

Image
本文或本章節是關於未來的公共运输建設或計划。 未有可靠来源的臆測內容可能會被移除，現時內容可能與竣工情況有所出入。 本文或本章節是關於澳門未來的建設或計畫 。 它可能包含推测的性质的信息，可能與竣工情況有所出入。 body.skin-minerva .mw-parser-output table.infobox caption{text-align:center} 澳門輕軌系統 葡萄牙語： Sistema de Metro Ligeiro de Macau 英语： Macau Light Rapid Transit System (Macau LRT System) 概覽 營運地區   澳門 服務類型 輕軌運輸 车站总数 氹仔線：11個 澳門半島線：10個 起訖站点 關閘 正線总数 3條 主要路線 海洋 - 氹仔碼頭 路線等級 輕軌 主要車站 蓮花口岸、 機場、氹仔碼頭 技術數據 路線長度 氹仔線：9.3公里 軌道標準 膠輪路軌系統 动力方式 第三軌供電 750V 車輛基地 計劃興建總數11個： 澳門半島6個，氹仔5個 运营信息 營運時期 氹仔線：預計於2019年 运营单位 港鐵（澳門）（2019年－2023年） 澳門輕軌股份有限公司（2023年後） 網站 http://www.git.gov.mo 路線圖 各期工程完成後的路線走向（模擬）圖 澳門輕軌系統（未來） 圖例 關閘 馬場北 馬場東 青洲 A區車廠 筷子基 新城A區01 紅街市
Read more

水泉澳邨

Image
水泉澳邨 //upload.wikimedia.org/wikipedia/commons/6/66/Shui_Chuen_O_Estate_Overview_2016.jpg 水泉澳邨航拍圖 房屋機構 香港房屋委員會 所屬地區 沙田區 屋邨類別 租住屋邨 入伙年份 2015年至2017年 樓宇座數 18 單位數目 11123 單位面積 151.23-397.73 呎（ft²） 住戶數目 10900 （截至2017年6月30日情況） 認可人口 28200 （截至2017年6月30日情況） 水泉澳邨內貌（2016年3月） 水泉澳邨 （ 英语： Shui Chuen O Estate ） [1] 是香港房屋委員會轄下的一個公共屋邨。全邨共分4期興建及管理，第1及2期樓宇由水泉澳邨辦事處管轄，第3及4期樓宇則由水泉澳邨辦事處分處管轄。項目編號為ST41，但已列入擴展市區配屋區內，位於香港新界沙田區水泉澳（沙田第52區）博泉街1號，已經興建18座樓高25至30層依山而建的住宅樓宇，共提供11,123個出租公屋單位，可容納人口逾29,000多人及水泉澳廣場，場內設有59個商舖及一個整體出租街市。水泉澳邨將設有行人天橋和升降機塔，接通博康邨和港鐵馬鞍山綫的沙田圍站；邨內亦設有公共交通交匯處及泊車位，方便居民出行。 整個項目於2015年4月至2017年3月分階段落成。整個項目由房屋署總建築師（1）負責總體設計；而詳細設計則拆細並以外判服務合約方式，第1及4期判給了周林建築師有限公司；第2A期（明泉樓、社會福利大樓、巴士總站、天橋及商場）及第3期（茂泉、林泉、修泉及竹泉樓）判給了興業建築師事務所有限公司及第2B期（月泉及映泉樓）判給了李景勳、雷煥庭建築師事務所；而第2C期（城泉及河泉樓）則由房屋署自行負責細部設計。全邨的總承建商是中國建築工程（香港）有限公司。 水泉澳邨共有18座出租公屋大樓，共分4期興建，第1期於2015年4月至7月底分2個階段完工，第2期在2016年3月至11月底分4個階段完工，第3期已於2017年2月完工交樓，第4期的嶺泉樓早已於2016年8月完工入伙，而餘下的崇泉、山泉及峻泉樓則由20
Read more

Indian Forest Service

Image
Indian Forest Service Service Overview Preceding service Imperial Forest Service (1864 to 1935) Year of Constitution 1966 Country India Staff College Indira Gandhi National Forest Academy (IGNFA), Dehradun, Uttarakhand Cadre Controlling Authority Ministry of Environment, Forests and Climate Change Legal personality Governmental: Government service General nature Administration of Forest and Wildlife resources Cadre strength 3131 (2182 Direct Recruits and 949 Promotion Posts) Website ifs.nic.in Service Chief Director General of Forests Siddhanth Das, IFS (1982 Batch, Odisha Cadre) [1] Head of the All India Civil Services Cabinet Secretary Pradeep Kumar Sinha, IAS Indian Forest Service (भारतीय वन सेवा) [2] is one of the three All India Services of the Government of India. The other two All India Services being the Indian Administrative Service (IAS) and the Indian Police Service (IPS). [3] [4] [5] It was constituted in
Read more